The application of autologous platelet rich fibrin reduces allogeneic blood transfusions and improves wound healing in total hip arthroplasty

The application of autologous platelet rich fibrin reduces allogeneic blood transfusions and improves wound healing in total hip arthroplasty - Platelet rich fibrin in THA (total hip arthroplasty)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON29827

Enrollment

152

Registered

2006-11-30

Start date

2007-03-06

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coxarthrosis

Interventions

Intra-operatively, after spinal anaesthesia has been administered, a volume of 120 ml of whole blood will be collected, through a peripheral line in the median cubital vein, in a special reservoir c

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: patients with primary ostheoarthritis who need total hip arthroplasty

Exclusion criteria

Exclusion criteria: coagulation diseases, use of anticoagulant drugs, renal problems or failure, liver disease, and malignant disease

Design outcomes

Primary

Measure	Time frame
Transfusion of homologous blood products Surgical wound healing	—

Secondary

Measure	Time frame
Patient characteristics Surgical wound leakage Surgical wound infection Pain medication Risk factors for wound healing disturbances Red Blood Cell Mass Surgical information PRF application-data Blood management-data	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)